Rabinowits, G., J. Homsi, M. Nikanjam, R. Gentry, J. Strasswimmer, S. Venna, M. Migden, S. Chandra, E. Ruiz, H. Zhang, J. McGinniss, A. Seluzhytsky, and J. Desai. “Demographics, Prior Therapies, and Reasons for Cemiplimab Treatment: Prospective CemiplimAb-Rwlc Survivorship and Epidemiology (C.A.S.E.) Study in Patients With Advanced Cutaneous Squamous Cell Carcinoma”. SKIN The Journal of Cutaneous Medicine, vol. 4, no. 6, Oct. 2020, p. s125, doi:10.25251/skin.4.supp.125.